Skip To Main Content
Aura Serrano on Muck Rack

Aura Serrano

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Aura Serrano’s profile

Articles by Aura Serrano

The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer

|
By Lucy Roxana Haggstrom, Andrew Parker, Andrew Ong, Janne Bingham, Dhanusha Sabanathan, Andrew Spillane, Aura Serrano, Geoffrey J Lindeman, Alexander Swarbrick, Alan S. Coates, G. Bruce Mann, Wayne D. Tilley, Elgene Lim, Davendra Segara, Emma-Kate Carson, Belinda. E. Kiely, Kate Saw
| Nature Verified
Abstract Progesterone can inhibit tumoural proliferation in oestrogen receptor positive (ER+) breast cancer. The WinPro trial (Australian New Zealand Trials Clinical Trials Registry number: ACTRN12618000928213, date of registration 01/06/2018) was a randomised, multi-centre, phase 2, window-of-opportunity trial evaluating micronised progesterone (MP) in post-menopausal women with early-stage, ER+, progesterone receptor (PR) positive, HER2- breast cancer.
Open in Who Shared Issue with article?
Show More